DARE TO CARE: EXPLORING WEIGHT LOSS DRUGS
Exercise physiologist, Katie Stewart, and pharmacist, Jason Chew, invite you to this exclusive event, Dare to Care: Exploring Weight Loss Drugs with special guest, Professor Rob Newton PhD, DSc, AEP, CSCS*D, FACSM, FESSA, FNSCA — Professor of Exercise Medicine and Deputy Director of Edith Cowan University’s Exercise Medicine Research Institute, that he established in 2004.
WHEN: Monday, 13 May 2024, from 5.30pm to 6.30pm (please arrive and take your seat by 5.15pm in advance of the 5.30pm start).
WHERE: Chronic Care Australia, Cottesloe Medical Centre, 525 Stirling Hwy, Cottesloe.
COST: FREE (We invite attendees to make a $10 tax deductible donation to CCA’s Community Programs upon arrival at each talk).*
You will gain insight into:
✚The pharmaceutical agents behind cutting-edge GLP-1 weight loss drugs like Semaglutide (aka Ozempic); and understand how they interact with the most powerful pharmaceutical resource in the human body – our muscles.
✚ The difference between GLP-1 & GLP-2 weight loss drugs, and how they can be best utilised.
✚ The crucial relationship between weight loss medications and muscle mass, and the importance of incorporating exercise into medical prescriptions.
✚ The need for self agency when it comes to obtaining knowledge about disease prevention and mitigating secondary injuries or illnesses.
✚ Understanding the significance of BMI and its relevance in metabolic health.
Join Katie, Jason and Professor Newton as they Dare to Care and unlock the keys to sustainable weight loss together.
Your contributions to CCA's Community Programs will help foster health equity and improve the lives of West Australians who are living with complex chronic conditions.
